279 related articles for article (PubMed ID: 35154090)
1. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
Juanes-Velasco P; Landeira-Viñuela A; García-Vaquero ML; Lecrevisse Q; Herrero R; Ferruelo A; Góngora R; Corrales F; Rivas JL; Lorente JA; Hernández ÁP; Fuentes M
Front Immunol; 2022; 13():732197. PubMed ID: 35154090
[TBL] [Abstract][Full Text] [Related]
2. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
Root-Bernstein R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
[TBL] [Abstract][Full Text] [Related]
3. Immune Responses to the Novel Coronavirus-2: Friend or Foe?
Mahmoodpoor A; Nader ND
Immunol Invest; 2021 Nov; 50(8):949-951. PubMed ID: 32689852
[No Abstract] [Full Text] [Related]
4. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
5. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
6. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
[No Abstract] [Full Text] [Related]
7. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
[TBL] [Abstract][Full Text] [Related]
8. Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice.
Bi Z; Hong W; Que H; He C; Ren W; Yang J; Lu T; Chen L; Lu S; Peng X; Wei X
Signal Transduct Target Ther; 2021 Dec; 6(1):439. PubMed ID: 34952899
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a
Anft M; Paniskaki K; Blazquez-Navarro A; Doevelaar A; Seibert FS; Hölzer B; Skrzypczyk S; Kohut E; Kurek J; Zapka J; Wehler P; Kaliszczyk S; Bajda S; Thieme CJ; Roch T; Konik MJ; Berger MM; Brenner T; Kölsch U; Meister TL; Pfaender S; Steinmann E; Tempfer C; Watzl C; Dolff S; Dittmer U; Abou-El-Enein M; Westhoff TH; Witzke O; Stervbo U; Babel N
Mol Ther; 2020 Dec; 28(12):2691-2702. PubMed ID: 33186542
[TBL] [Abstract][Full Text] [Related]
10. Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.
Fang XZ; Wang YX; Xu JQ; He YJ; Peng ZK; Shang Y
Front Immunol; 2021; 12():651545. PubMed ID: 34149692
[TBL] [Abstract][Full Text] [Related]
11. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
[TBL] [Abstract][Full Text] [Related]
12. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
Monreal E; Maza S S; Gullón P; Natera-Villalba E; Chico-García JL; Beltrán-Corbellini Á; Martínez-Sanz J; García-Barragán N; Buisán J; Toledano R; Alonso-Canovas A; Pérez-Torre P; Matute-Lozano MC; López-Sendón JL; García-Ribas G; Corral Í; Fortún J; Montero-Errasquín B; Manzano L; Máiz-Carro L; Costa-Frossard L; Masjuan J;
J Med Virol; 2021 Apr; 93(4):2243-2251. PubMed ID: 33165922
[TBL] [Abstract][Full Text] [Related]
13. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Cerro Chiang G; Kassar AG; Patel N; Green CER; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
Cell Rep; 2021 Jan; 34(1):108590. PubMed ID: 33357411
[TBL] [Abstract][Full Text] [Related]
14. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.
Carcaterra M; Caruso C
Med Hypotheses; 2021 Jan; 146():110412. PubMed ID: 33308936
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
Reizine F; Lesouhaitier M; Gregoire M; Pinceaux K; Gacouin A; Maamar A; Painvin B; Camus C; Le Tulzo Y; Tattevin P; Revest M; Le Bot A; Ballerie A; Cador-Rousseau B; Lederlin M; Lebouvier T; Launey Y; Latour M; Verdy C; Rossille D; Le Gallou S; Dulong J; Moreau C; Bendavid C; Roussel M; Cogne M; Tarte K; Tadié JM
J Clin Immunol; 2021 Apr; 41(3):515-525. PubMed ID: 33387156
[TBL] [Abstract][Full Text] [Related]
17. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
[TBL] [Abstract][Full Text] [Related]
18. Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS.
García-Hidalgo MC; González J; Benítez ID; Carmona P; Santisteve S; Pérez-Pons M; Moncusí-Moix A; Gort-Paniello C; Rodríguez-Jara F; Molinero M; Belmonte T; Torres G; Labarca G; Nova-Lamperti E; Caballero J; Bermejo-Martin JF; Ceccato A; Fernández-Barat L; Ferrer R; Garcia-Gasulla D; Menéndez R; Motos A; Peñuelas O; Riera J; Torres A; Barbé F; de Gonzalo-Calvo D;
Emerg Microbes Infect; 2022 Dec; 11(1):1537-1549. PubMed ID: 35603455
[TBL] [Abstract][Full Text] [Related]
19. A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host.
Minakshi R; Jan AT; Rahman S; Kim J
Front Cell Infect Microbiol; 2020; 10():575404. PubMed ID: 33262955
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
